161 related articles for article (PubMed ID: 10536012)
1. The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: implications for multiple sclerosis treatment.
Bourrié B; Bribes E; Esclangon M; Garcia L; Marchand J; Thomas C; Maffrand JP; Casellas P
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12855-9. PubMed ID: 10536012
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis.
Liu Y; Zhu B; Wang X; Luo L; Li P; Paty DW; Cynader MS
J Neuroimmunol; 2003 Jun; 139(1-2):27-35. PubMed ID: 12799017
[TBL] [Abstract][Full Text] [Related]
3. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
4. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
[TBL] [Abstract][Full Text] [Related]
5. Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats.
Chen GQ; Chen YY; Wang XS; Wu SZ; Yang HM; Xu HQ; He JC; Wang XT; Chen JF; Zheng RY
Brain Res; 2010 Jan; 1309():116-25. PubMed ID: 19879252
[TBL] [Abstract][Full Text] [Related]
6. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Paris D; Beaulieu-Abdelahad D; Mullan M; Ait-Ghezala G; Mathura V; Bachmeier C; Crawford F; Mullan MJ
PLoS One; 2013; 8(1):e55392. PubMed ID: 23383175
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats.
Abdin AA; Hasby EA
Eur J Pharmacol; 2014 Nov; 742():102-12. PubMed ID: 25218987
[TBL] [Abstract][Full Text] [Related]
9. An aza-anthrapyrazole negatively regulates Th1 activity and suppresses experimental autoimmune encephalomyelitis.
Clark MP; Leaman DW; Hazelhurst LA; Hwang ES; Quinn A
Int Immunopharmacol; 2016 Feb; 31():74-87. PubMed ID: 26709219
[TBL] [Abstract][Full Text] [Related]
10. Th1 and Th2 cytokine immunomodulation by gangliosides in experimental autoimmune encephalomyelitis.
Monteiro de Castro G; Eduarda Zanin M; Ventura-Oliveira D; Aparecida Vilella C; Ashimine R; de Lima Zollner R
Cytokine; 2004 May; 26(4):155-63. PubMed ID: 15149632
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of bornyl acetate on experimental autoimmune encephalomyelitis via anti-inflammatory effects and maintaining blood-brain-barrier integrity.
Lee JI; Choi JH; Kwon TW; Jo HS; Kim DG; Ko SG; Song GJ; Cho IH
Phytomedicine; 2023 Apr; 112():154569. PubMed ID: 36842217
[TBL] [Abstract][Full Text] [Related]
12. Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.
Soleimani M; Jameie SB; Barati M; Mehdizadeh M; Kerdari M
Iran Biomed J; 2014; 18(4):203-11. PubMed ID: 25326018
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
Paintlia AS; Paintlia MK; Singh I; Singh AK
Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of oral administration of C-Phycocyanin and Phycocyanobilin in rodent models of experimental autoimmune encephalomyelitis.
Cervantes-Llanos M; Lagumersindez-Denis N; Marín-Prida J; Pavón-Fuentes N; Falcon-Cama V; Piniella-Matamoros B; Camacho-Rodríguez H; Fernández-Massó JR; Valenzuela-Silva C; Raíces-Cruz I; Pentón-Arias E; Teixeira MM; Pentón-Rol G
Life Sci; 2018 Feb; 194():130-138. PubMed ID: 29287781
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration.
Schmidt J; Stürzebecher S; Toyka KV; Gold R
J Neurosci Res; 2001 Jul; 65(1):59-67. PubMed ID: 11433430
[TBL] [Abstract][Full Text] [Related]
17. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
Mondal S; Pahan K
PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
[TBL] [Abstract][Full Text] [Related]
19. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Yang JS; Xu LY; Xiao BG; Hedlund G; Link H
J Neuroimmunol; 2004 Nov; 156(1-2):3-9. PubMed ID: 15465591
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
